Cart
sales@molnova.com
(+)-beta-Cedrene
CAS No. 546-28-1
(+)-beta-Cedrene( —— )
Catalog No. M32377 CAS No. 546-28-1
β-cedrene are bioactive sesquiterpenes found in cedar essential oil and exert antiseptic, anti-inflammatory, antispasmodic, tonic, astringent, diuretic, sedative, insecticidal, and antifungal activities.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name(+)-beta-Cedrene
-
NoteResearch use only, not for human use.
-
Brief Descriptionβ-cedrene are bioactive sesquiterpenes found in cedar essential oil and exert antiseptic, anti-inflammatory, antispasmodic, tonic, astringent, diuretic, sedative, insecticidal, and antifungal activities.
-
Descriptionβ-cedrene are bioactive sesquiterpenes found in cedar essential oil and exert antiseptic, anti-inflammatory, antispasmodic, tonic, astringent, diuretic, sedative, insecticidal, and antifungal activities. β-Cedrene is a potent and competitive inhibitor of CYP2B6-mediated bupropion hydroxylase, and β-cedrene moderately blocks CYP3A4.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number546-28-1
-
Formula Weight204.35
-
Molecular FormulaC15H24
-
Purity>98% (HPLC)
-
SolubilityDMSO, Pyridine, Methanol, Ethanol, etc.
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Physiol Behav . 2018 May 15;189:50-58.
molnova catalog
related products
-
Tumulosic acid
Tumulosic acid is a natural product for research related to life sciences.
-
JKE-1674
JKE-1674 is an inhibitor of glutathione peroxidase 4 (GPX4). JKE-1674 is an active metabolite of the GPX4 inhibitor ML-210.
-
Neoastragaloside I
Neoastragaloside I is a natural product.
